{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:05:45Z","timestamp":1792098345395,"version":"4.4.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1097\/nrl.0b013e318187e76b","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T21:00:31Z","timestamp":1242939631000},"page":"80-86","source":"Crossref","is-referenced-by-count":95,"title":["Genetic Aspects of Alzheimer Disease"],"prefix":"10.1097","volume":"15","author":[{"given":"Jennifer","family":"Williamson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.","family":"Marder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-5-20210211","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1007\/s00018-007-7219-3","article-title":"The molecular link between beta- and gamma-secretase activity on the amyloid beta precursor protein.","volume":"64","author":"Tabaton","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"R3-5-20210211","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/hmg\/5.7.985","article-title":"Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant.","volume":"5","author":"Sherrington","year":"1996","journal-title":"Hum Mol Genet"},{"key":"R4-5-20210211","first-page":"273","article-title":"Assessment of amyloid beta-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases.","volume":"51","author":"Tanzi","year":"1992","journal-title":"Am J Hum Genet"},{"key":"R5-5-20210211","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1126\/science.1411576","article-title":"Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14.","volume":"258","author":"Schellenberg","year":"1992","journal-title":"Science"},{"key":"R6-5-20210211","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ng1292-335","article-title":"Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3.","volume":"2","author":"Van Broeckhoven","year":"1992","journal-title":"Nat Genet"},{"key":"R7-5-20210211","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ng1292-330","article-title":"Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14.","volume":"2","author":"St George-Hyslop","year":"1992","journal-title":"Nat Genet"},{"key":"R8-5-20210211","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/376775a0","article-title":"Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene.","volume":"376","author":"Rogaev","year":"1995","journal-title":"Nature"},{"key":"R9-5-20210211","first-page":"1034","article-title":"Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage.","volume":"48","author":"Pericak-Vance","year":"1991","journal-title":"Am J Hum Genet"},{"key":"R10-5-20210211","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0694-180","article-title":"Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.","volume":"7","author":"Corder","year":"1994","journal-title":"Nat Genet"},{"key":"R11-5-20210211","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"R12-5-20210211","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/jama.287.3.329","article-title":"Risk of dementia among white and African American relatives of patients with Alzheimer disease.","volume":"287","author":"Green","year":"2002","journal-title":"JAMA"},{"key":"R13-5-20210211","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/archneur.59.1.87","article-title":"Familial Alzheimer disease among Caribbean Hispanics: a reexamination of its association with APOE.","volume":"59","author":"Romas","year":"2002","journal-title":"Arch Neurol"},{"key":"R14-5-20210211","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng1934","article-title":"Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.","volume":"39","author":"Bertram","year":"2007","journal-title":"Nat Genet"},{"key":"R15-5-20210211","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1126\/science.273.5281.1516","article-title":"The future of genetic studies of complex human diseases.","volume":"273","author":"Risch","year":"1996","journal-title":"Science"},{"key":"R16-5-20210211","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neurobiolaging.2004.04.004","article-title":"Complete ascertainment of dementia in the Swedish Twin Registry: the HARMONY study.","volume":"26","author":"Gatz","year":"2005","journal-title":"Neurobiol Aging"},{"key":"R17-5-20210211","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","article-title":"Role of genes and environments for explaining Alzheimer disease.","volume":"63","author":"Gatz","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"R18-5-20210211","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1093\/hmg\/ddl178","article-title":"DAPK1 variants are associated with Alzheimer's disease and allele-specific expression.","volume":"15","author":"Li","year":"2006","journal-title":"Hum Mol Genet"},{"key":"R19-5-20210211","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1172\/JCI24761","article-title":"The genetic epidemiology of neurodegenerative disease.","volume":"115","author":"Bertram","year":"2005","journal-title":"J Clin Invest"},{"key":"R20-5-20210211","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/(SICI)1097-4547(19991201)58:5<674::AID-JNR8>3.0.CO;2-3","article-title":"Developmental changes in distribution of death-associated protein kinase mRNAs.","volume":"58","author":"Yamamoto","year":"1999","journal-title":"J Neurosci Res"},{"key":"R21-5-20210211","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1083\/jcb.151.4.847","article-title":"Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation.","volume":"151","author":"Mah","year":"2000","journal-title":"J Cell Biol"},{"key":"R23-5-20210211","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1212\/01.WNL.0000140292.04932.87","article-title":"Hyperinsulinemia and risk of Alzheimer disease.","volume":"63","author":"Luchsinger","year":"2004","journal-title":"Neurology"},{"key":"R24-5-20210211","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1126\/science.290.5500.2302","article-title":"Evidence for genetic linkage of Alzheimer's disease to chromosome 10q.","volume":"290","author":"Bertram","year":"2000","journal-title":"Science"},{"key":"R25-5-20210211","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/jmg.2006.048470","article-title":"Insulin-degrading enzyme is genetically associated with Alzheimer's disease in the Finnish population.","volume":"44","author":"Vepsalainen","year":"2007","journal-title":"J Med Genet"},{"key":"R26-5-20210211","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neulet.2004.07.070","article-title":"Possible association of mitochondrial transcription factor A (TFAM) genotype with sporadic Alzheimer disease.","volume":"369","author":"Gunther","year":"2004","journal-title":"Neurosci Lett"},{"key":"R27-5-20210211","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.neuron.2007.05.022","article-title":"GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.","volume":"54","author":"Reiman","year":"2007","journal-title":"Neuron"},{"key":"R28-5-20210211","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/ng1943","article-title":"The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease.","volume":"39","author":"Rogaeva","year":"2007","journal-title":"Nat Genet"},{"key":"R29-5-20210211","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nbd.2007.09.001","article-title":"SORL1 variants and risk of late-onset Alzheimer's disease.","volume":"29","author":"Li","year":"2008","journal-title":"Neurobiol Dis"},{"key":"R30-5-20210211","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/WNR.0b013e3282f13e7a","article-title":"Association between SORL1 and Alzheimer's disease in a genome-wide study.","volume":"18","author":"Meng","year":"2007","journal-title":"Neuroreport"},{"key":"R31-5-20210211","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000110789","article-title":"Sorl1 as an Alzheimer's disease predisposition gene?","volume":"5","author":"Webster","year":"2008","journal-title":"Neurodegener Dis"},{"key":"R32-5-20210211","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1172\/JCI25421","article-title":"Mapping the new frontier: complex genetic disorders.","volume":"115","author":"Mayeux","year":"2005","journal-title":"J Clin Invest"},{"key":"R33-5-20210211","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.GIM.0000132679.92238.58","article-title":"Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study.","volume":"6","author":"Cupples","year":"2004","journal-title":"Genet Med"},{"key":"R34-5-20210211","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11910-004-0081-x","article-title":"Genetics and genetic counseling: recommendations for Alzheimer's disease, frontotemporal dementia, and Creutzfeldt-Jakob disease.","volume":"4","author":"Williamson","year":"2004","journal-title":"Curr Neurol Neurosci Rep"},{"key":"R35-5-20210211","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1001\/jama.286.18.2257","article-title":"A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families.","volume":"286","author":"Athan","year":"2001","journal-title":"JAMA"},{"key":"R36-5-20210211","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/302553","article-title":"Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.","volume":"65","author":"Campion","year":"1999","journal-title":"Am J Hum Genet"},{"key":"R37-5-20210211","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/jama.1997.03540340066035","article-title":"The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective.","volume":"277","author":"Post","year":"1997","journal-title":"JAMA"},{"key":"R38-5-20210211","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1749-6632.1996.tb32608.x","article-title":"The National Institute on Aging\/Alzheimer's Association recommendations on the application of apolipoprotein E genotyping to Alzheimer's disease.","volume":"802","author":"Relkin","year":"1996","journal-title":"Ann N Y Acad Sci"},{"key":"R39-5-20210211","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1056\/NEJM199802193380804","article-title":"Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.","volume":"338","author":"Mayeux","year":"1998","journal-title":"N Engl J Med"},{"key":"R40-5-20210211","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1172\/JCI8593","article-title":"A genetic dichotomy model for the inheritance of Alzheimer's disease and common age-related disorders.","volume":"104","author":"Tanzi","year":"1999","journal-title":"J Clin Invest"},{"key":"R41-5-20210211","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/0891988705281883","article-title":"Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study.","volume":"18","author":"Roberts","year":"2005","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"R42-5-20210211","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/jama.274.20.1627","article-title":"Statement on use of apolipoprotein E testing for Alzheimer disease. American College of Medical Genetics\/American Society of Human Genetics Working Group on ApoE and Alzheimer disease.","volume":"274","year":"1995","journal-title":"JAMA"},{"key":"R43-5-20210211","first-page":"1533","article-title":"Guidelines for the molecular genetics predictive test in Huntington's disease. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea.","volume":"44","year":"1994","journal-title":"Neurology"}],"container-title":["The Neurologist"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00127893-200903000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:23:53Z","timestamp":1618035833000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00127893-200903000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/nrl.0b013e318187e76b","relation":{},"ISSN":["1074-7931"],"issn-type":[{"value":"1074-7931","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}